Skip to main page content

• HOME
• Current
• Archive
• Feedback
• Subscribe
• Help

The British Journal of Psychiatry (2006) 188: 510-518. doi: 10.1192/bjp.188.6.510
© 2006 The Royal College of Psychiatrists

This Article Abstract Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Related articles in BJP Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by STEEN, R. G. Articles by LIEBERMAN, J. A. Search for Related Content PubMed PubMed Citation Articles by STEEN, R. G. Articles by LIEBERMAN, J. A.

REVIEW ARTICLE

Brain volume in first-episode schizophrenia

Systematic review and meta-analysis of magnetic resonance imaging studies

R. GRANT STEEN, PhD, COURTNEY MULL, MD, ROBERT MCCLURE, MD, ROBERT M. HAMER, PhD and JEFFREY A. LIEBERMAN, MD

Department of Psychiatry, University of North Carolina at Chapel Hill, North Carolina, USA

Correspondence: Dr R. Grant Steen, Department of Psychiatry, University of North Carolina at Chapel Hill, Campus Box 7160, Chapel Hill, North Carolina 27599-7160, USA. Tel: +1 919 966 8382; e-mail: Grant_Steen{at}med.unc.edu

Declaration of interest None.

TOP ABSTRACT INTRODUCTION METHOD RESULTS DISCUSSION ACKNOWLEDGMENTS REFERENCES

 
Background Studies of people with schizophrenia assessed using magnetic resonance imaging (MRI) usually include patients with first-episode and chronic disease, yet brain abnormalities may be limited to those with chronic schizophrenia.

Aims To determine whether patients with a first episode of schizophrenia have characteristic brain abnormalities.

Method Systematic review and meta-analysis of 66 papers comparing brain volume in patients with a first psychotic episode with volume in healthy controls.

Results A total of 52 cross-sectional studies included 1424 patients with a first psychotic episode; 16 longitudinal studies included 465 such patients. Meta-analysis suggests that whole brain and hippocampal volume are reduced (both P<0.0001) and that ventricular volume is increased (P<0.0001) in these patients relative to healthy controls.

Conclusions Average volumetric changes are close to the limit of detection by MRI methods. It remains to be determined whether schizophrenia is a neurodegenerative process that begins at about the time of symptom onset, or whether it is better characterised as a neurodevelopmental process that produces abnormal brain volumes at an early age.

TOP ABSTRACT INTRODUCTION METHOD RESULTS DISCUSSION ACKNOWLEDGMENTS REFERENCES

 
Schizophrenia is a disabling illness that affects over 2 million people in the USA alone, but its aetiology remains poorly understood (Harrison, 1999; Siever & Davis, 2004). In past years the disorder was studied by examining pathological brain tissue samples, often derived from patients who had died after a prolonged period of illness. In recent years, with the advent of brain imaging methods such as magnetic resonance imaging (MRI), it has become possible to study patients during their first episode of psychosis, before disease effects are obscured by the confounding influences typical of cases of chronic schizophrenia. This may make it possible to test hypotheses as to which brain volumetric changes are primary to the development of schizophrenia (Shenton et al, 2001). Our goal in the study reported here is to provide an update of two excellent earlier reviews (Wright et al, 2000; Shenton et al, 2001), but with a focus specifically on patients with first-episode schizophrenia.

TOP ABSTRACT INTRODUCTION METHOD RESULTS DISCUSSION ACKNOWLEDGMENTS REFERENCES

 
Study selection criteria
Relevant studies of patients with first-episode schizophrenia were identified in multiple searches as late as November 2004. The primary search used PubMed and the keywords SCHIZOPHRENIA and FIRST-EPISODE and MAGNETIC RESONANCE IMAGING and VOLUME, in all possible combinations. This search was repeated, substituting the keyword DRUG NAIVE for FIRST-EPISODE, and using the same search words again in all possible combinations. A secondary search was then undertaken, using each primary reference as a source. The bibliography of each source was searched for additional references that were missed by the PubMed search. In addition, the bibliographies of eight key review articles were searched (Wright et al, 2000; Konick & Friedman, 2001; Okubo et al, 2001; Shenton et al, 2001; Kasai et al, 2002; Torrey, 2002; Davidson & Heinrichs, 2003; Antonova et al, 2004) for papers relating specifically to patients with first-episode disorder. Finally, current journals were reviewed to find references too new to have been reviewed. The primary search found 75 relevant references, whereas the secondary searches found an additional 16 references.

Studies were included in our analysis if brain MRI volumetric data were reported for both a population of patients with schizophrenia at first episode and a population of healthy controls evaluated concurrently. We excluded seven studies that did not report exclusively on patients with first-episode illness, and five studies that did not report concurrent data from healthy controls. Studies were also excluded if data from patients with first-episode psychosis were not separated from a larger population of patients with psychosis of some other type, or if results included patients with childhood-onset schizophrenia. We specifically excluded children younger than age 13 years from our analysis because there are rapid changes in brain volume among healthy children up to about age 9 years (Pfefferbaum et al, 1994; Giedd et al, 1999), and the young age of patients with childhood-onset illness would make it difficult to control adequately for the effects of normal brain growth. Studies were also excluded if data were reported in a format that did not enable us to calculate patient brain volume as a percentage of the control group volume. Thus, we excluded studies that used voxel-based morphometry, since our calculations are based on volume rather than on number of pixels. We also excluded studies that reported results from a non-volumetric analysis of the data, or from a non-quantitative analysis of the data.

Of the total of 91 articles that were originally identified, 26 were excluded for any of the above reasons. A total of 65 articles were evaluated (Table 1), including 52 cross-sectional and 16 longitudinal studies. Data from all 52 eligible cross-sectional studies were entered into a spreadsheet that tabulated study details, including a brief description of the study, demography of the study populations, patient medications and the statistical analyses used. For patients, additional data were entered summarising the percentage difference in structure volume relative to controls, and whether or not this difference was statistically significant according to the analysis presented in the original reference.

View this table: [in this window] [in a new window]

Table 1 Summary of cross-sectional and longitudinal studies included in review

The data entry process was then repeated for all eligible longitudinal studies. If a longitudinal study reported baseline data in a format that could be analysed as a cross-sectional study, this study was entered into both the cross-sectional and the longitudinal databases. The final database contained approximately 29 084 cells.

Data analysis
We sorted the cross-sectional database by brain structure, to determine where brain volumetric changes had been sought. Brain volume changes in the first-episode group were summarised, with respect to controls, on a structure-by-structure basis (further information available from the author upon request). We then conducted a meta-analysis of all cross-sectional studies that measured whole-brain volume in the first-episode group relative to controls (Table 2). For each component study in the meta-analysis, we abstracted information about sample properties (size, mean and standard deviation) from the original paper and fitted a blocked analysis of variance model (with study as the blocking factor) to examine group differences. We additionally fitted models with the groupxtreatment interaction, to assess heterogeneity; interactions were non-significant in all cases, so we used the models without the interaction terms. We did similar meta-analyses of cross-sectional studies that measured differences in hippocampal volume (Table 3) and ventricular volume (Table 4). Finally, we summarised all studies that reported longitudinal volumetric changes significant at P0.01 (further information available from the author upon request), to address the issue of which longitudinal changes are most robust by statistical criteria.

View this table: [in this window] [in a new window]

Table 2 Whole-brain volume in cross-sectional studies

View this table: [in this window] [in a new window]

Table 3 Hippocampal volume in cross-sectional studies

View this table: [in this window] [in a new window]

Table 4 Ventricular volume in cross-sectional studies

TOP ABSTRACT INTRODUCTION METHOD RESULTS DISCUSSION ACKNOWLEDGMENTS REFERENCES

 
The primary PubMed search was able to find 75 of the 91 papers evaluated in this study, or 82% of the relevant references. This suggests that PubMed, although an effective tool, cannot be relied upon to find all relevant references.

A total of 52 studies were included in the cross-sectional analysis (Table 1), these studies involving 1424 patients with first-episode schizophrenia (30.3 patients per study, s.d.=16.5) and 1315 healthy controls (28.0 controls per study, s.d.=10.7). A total of 16 studies were included in the longitudinal analysis, these studies involving 465 patients (33.2 patients per study, s.d.=26.9) and 240 healthy controls (17.1 controls per study, s.d.=8.8). The average age of patients across all studies was 26 years. Even after excluding studies that comprised only male patients (reasoning that a study with a sample composed only of men must have made an effort to exclude women), roughly two-thirds of patients were men, suggesting that males are more common among young patients with first episodes of schizophrenia.

Relatively few brain structures have been evaluated in multiple studies (further information available from the author upon request); of 14 comparisons that showed a significant volumetric decrease in grey matter of patients’ brains, only 6 comparisons were replicated more than three times. Most volumetric studies were small, even when the focus was a structure in which measurement error could be substantial. The total number of patients evaluated per structure, averaged across all 14 central grey matter structures, was 97.6 (s.d.=82.5), but it was only 65.5 (s.d.=47.6) if amygdala, hippocampus and the amygdala– hippocampal complex were excluded. Most volumetric changes that are significant relate to grey matter, and more findings relate to central than to peripheral (cortical) grey matter. Virtually all significant volumetric differences from normal in grey matter are patient deficits in volume, compared with controls.

Cross-sectional studies that measured whole-brain volume deficits in patients with first-episode schizophrenia are summarised in Table 2. For this particular comparison there have been 21 studies, with a large number of participants (patients, n=524; controls, n=650), but only 4 studies found significance. Meta-analysis showed that the average patient brain volume was 2.7% smaller than the average control brain volume (P<0.0001). Group (patient v. control) and study differences together account for 57% of the variation in brain volume, but group differences alone were able to account for less than 1% of the variation in brain volume (P<0.0001). Thus, there was a significant variation in brain volume between studies (P<0.0001), although there was no significant study heterogeneity.

There was variation in the number (and type) of covariates used in the various studies of brain volume, suggesting that it may be problematic to pool studies in a single meta-analysis. Nevertheless, the number of statistical covariates used in analysis did not seem to be related to the level of statistical significance obtained. The 4 studies that found significance had an average of 2.0 covariates, whereas the 17 non-significant studies had an average of 2.2 covariates.

Cross-sectional studies that measured hippocampal volume deficits in patients with first-episode schizophrenia are summarised in Table 3. There have been 10 separate studies of the hippocampus, with total participant numbers of 300 patients and 287 controls. Meta-analysis shows that the volume deficit in patient hippocampus is about 8% on both right and left sides (P<0.0001). This deficit is somewhat larger than the 4% volume deficit reported in a meta-analysis of hippocampal volume in patients with chronic schizophrenia (Nelson et al, 1998). Group and study differences together accounted for 64% of the variation in hippocampal volume, but group differences alone were able to account for only 2% of this variation (P<0.0001). Study-related variation in hippocampal volume was significant (P<0.0001), without significant study heterogeneity.

Cross-sectional studies that measured the lateral or third ventricles in patients with first-episode schizophrenia are also summarised (Table 4). There have been 11 studies of ventricular volume, with total participant numbers of 204 patients and 209 controls. Meta-analysis shows that the lateral ventricle volume surplus in patients is about 34% on the left side and 25% on the right side (both P<0.0001). Group and study differences together account for 31% of the variation in ventricular volume on the left side and 26% on the right side (both P<0.0001), with group differences accounting for 6% or less of the variation in ventricular volume (both P<0.0001). For third ventricle measurements, group and study differences together accounted for 68% of the variation in third ventricle volume (P<0.0001), with group differences accounting for 4% of the variation in ventricular volume. Study-related variation in ventricular volume was significant (all P<0.0001), without significant study heterogeneity.

We summarised robustly significant (P0.01) findings from longitudinal studies of brain volume change in patients (further information available from the author upon request). This compilation demonstrates that longitudinal studies are generally of recent vintage; of eight studies recorded, five were published within the past 5 years. Several longitudinal changes in the volume of the brain were robustly significant after diagnosis, including a significant decrease in volume of the whole brain after diagnosis. No significant longitudinal change was identified in white matter or cerebellum, so longitudinal changes in whole-brain volume may be limited to the grey matter.

TOP ABSTRACT INTRODUCTION METHOD RESULTS DISCUSSION ACKNOWLEDGMENTS REFERENCES

 
Our synthesis of brain volumetric studies suggests that a great deal more work is needed. There are relatively few studies that specifically relate to patients with first episodes of schizophrenia (see Table 1); the existing studies have a rather small sample size and studies that reported a high degree of significance tended to have a smaller sample size than normal. Most significant volumetric findings are not well replicated, and few findings are robustly significant, in either cross-sectional or longitudinal studies. Studies of patients with first episodes tend to be smaller than the average of 33 patients per study reported in a systematic review of 180 studies of patients with (mostly) chronic schizophrenia (Shenton et al, 2001). Thus, the total number of first-episode cases that have been evaluated overall is small, given the complexity of the illness.

Whole-brain volume deficits
Whole-brain volume differences between first-episode cases and controls are apparently quite subtle (Harrison et al, 2003). Cross-sectional studies that measured whole-brain volume reported an average volume deficit in the first-episode group of less than 3% (see Table 2), despite a large sample size. This finding agrees well with a study of brain weight at autopsy, in which 540 older patients with chronic schizophrenia were compared with 794 controls (Harrison et al, 2003). This study found that the brain weight of patients with chronic disorder was 2% less than that of healthy controls (P=0.04), but that disease-related differences were far less significant than brain weight differences attributable to either age or gender (both P<0.0001). No correlation was found between brain weight and the duration of psychosis, which may mean that brain atrophy is not progressive after diagnosis (Harrison et al, 2003).

It is critically important to determine when whole-brain volume deficits in patients with schizophrenia first become significant, as this could have bearing on the aetiology of the disorder (Harrison, 1999). If whole-brain volume becomes abnormal early in childhood, this would suggest a neurodevelopmental aetiology; alternatively, if whole-brain volume becomes abnormal shortly before the onset of symptoms – or even after symptoms have developed – this would suggest a neurodegenerative aetiology. Population-based data suggest that head size is abnormal at birth among those who later develop schizophrenia, compared with controls (Ward et al, 1996; Harrison, 1999). Research in the offspring of people with schizophrenia, in people at high genetic risk of this disorder or in patients in its prodromal phase might help to address this aetiological question.

When does volumetric change occur?
Some brain structures in people with first-episode schizophrenia appear to show a volumetric deficit that is significant at diagnosis and that is also progressive over the later course of illness. For example, the lateral ventricles are significantly larger than normal at diagnosis (Table 4) and ventricular volume tends to increase significantly in longitudinal studies. Volumetric deficits at diagnosis are seen in the hippocampus (Table 3), in cortical grey matter, in Heschl’s gyrus, in the planum temporale and in temporal grey matter, and all of these structures also show continued volumetric loss over time (further information available from the author upon request).

Some brain tissues appear to show a volumetric deficit at diagnosis, but the deficit may not progress over time. For example, there are volumetric deficits in the thalamus at diagnosis, according to four studies, but no longitudinal change has yet been described. Similarly, volume deficits in the insula are significant at diagnosis, according to two studies, but no longitudinal change has been described. This may mean that volumetric changes in the thalamus and insula are indeed not progressive, or it may mean that there are simply too few longitudinal studies to identify a progressive volume loss that is actually present in these structures.

Imaging difficulties
There are a great many difficulties in measuring brain volumes of patients with schizophrenia by MRI. A major problem is that the volumetric loss in patients is no more than 4% per year (further information available upon request), which may be close to the limit of detection by MRI, given the precision of volumetric methods (Howard et al, 2003; MacFall et al, 2004). A longitudinal study of a volume phantom found that changes of up to 5% could be introduced by changes in scanner hardware or software (MacFall et al, 2004). Such ‘machine drift’ can have an impact on volume measurement, as shown by a study of intracranial content in 113 healthy elderly participants (MacFall et al, 2004). Although the intracranial content cannot change after the cranial sutures close (Pfefferbaum et al, 1994; Giedd et al, 1999), error in its measurement averaged ±1.5% (MacFall et al, 2004). This error could be corrected but, in the absence of correction, would confound any longitudinal measurement of brain volume (MacFall et al, 2004). In studies that control for intracranial volume, imprecision or inaccuracy may not have a major impact, but poor precision or low accuracy in even a subset of volumetric studies would lead to a lack of consensus among the various studies.

Imprecision or inaccuracy in the measurement of brain volume can arise in many ways. Perhaps the most likely source of error is voxel misclassification during brain segmentation (Wang & Doddrell, 2002). Voxels classified as one tissue type could, with a relatively minor change in tissue T₁ or T₂, be classified as another tissue type (Steen et al, 1997). A second major issue is the familiar partial volume problem; since several tissues can occur in a volume much smaller than a typical imaging voxel, this would introduce error into the volume estimate of any tissue type (Tofts et al, 1997; Ballester et al, 2000; Wang & Doddrell, 2002), and could potentially change the proportional allocation of tissue to tissue type. A third problem is the inconspicuousness of tissue edges; this type of error is really another type of partial volume error that would primarily affect the estimate of grey matter volume, since this often has poorly defined edges with cerebrospinal fluid. Error in the measurement of grey matter volume would change the estimate of total brain volume, so controlling for brain volume would not necessarily eliminate ‘machine drift’ in a longitudinal study. A fourth issue is head tilt, or angulation of the imaging slab over the brain, since different volumes of brain may be interrogated in different imaging examinations. This problem can only be overcome by striving for full brain coverage during an examination. Finally, non-systematic non-systematic errors (mistakes) can be made during the complex analytic process that is required for MRI volumetry (Haller et al, 1997). In short, because error can be substantial and because brain volumetric changes from normal in patients with first-episode schizophrenia appear to be quite small, some of the differences reported between patients and controls (Tables 2, 3, 4) are probably artefactual.

Clinical difficulties
A great many clinical difficulties complicate a volumetric search for the causes of schizophrenia. An enormous problem is that patients are typically treated with antipsychotic medications as soon as possible after diagnosis. Different patients may receive different medications at different dosages, and such treatment heterogeneity is almost impossible to eliminate. This makes it essential to determine whether there are acute effects of medication on total brain volume (DeLisi et al, 1991; Chakos et al, 1994; Gur et al, 1998). If brain volumetric changes in response to medication are rapid, then the length of time between first medication and imaging evaluation could be a major confounder. Antipsychotic medication has been postulated to have an effect on basal ganglia volume in as little as 6 months (Chakos et al, 1994), and it is possible that brain volumetric change in response to medication occurs even more rapidly. A further difficulty inherent to studying first-episode cases is that some patients may have been symptomatic, but undiagnosed, for a long time. If progressive brain volume changes are rapid in the period surrounding diagnosis, then the duration of undiagnosed illness would be a serious confounder. However, since no consistent relationship has been found between duration of illness and brain volume loss (Harrison et al, 2003), this may be less likely.

Recruiting patients with schizophrenia can be time-consuming, difficult and expensive, since many are unable or unwilling to comply with study requirements. Another problem is that brain structure may be weakly correlated with brain function, so that substantial variation in brain volume could be found in the absence of any variation in brain function (Uttal, 2001). These two problems together probably account for why so many studies of brain volume appear to be underpowered (Table 2). Many studies lack a sample size sufficient to test hypotheses that relate to what may be an inherently weak relationship, especially given the limitations of the methods (Haller et al, 1997; Howard et al, 2003; MacFall et al, 2004). To complicate the picture further, there may be genetic heterogeneity within the diagnosis, such that patients in a single study might actually have different diseases that converge in causing psychotic symptoms.

Concluding remarks
The most robust volumetric findings in patients with schizophrenia are those of grey matter volume loss (Table 3) and ventricular volume increase (Table 4), and these findings are probably linked. In monozygotic twins discordant for schizophrenia, there is a correlation between reduced left temporal grey matter volume and increased volume of cerebrospinal fluid in the left temporal horn, suggesting that loss of grey matter leads to an increase in ventricular volume (Suddath et al, 1989). Many more longitudinal studies of brain volume change in patients with first psychotic episodes are needed to determine which tissues are prone to the atrophy that manifests as ventricular volume increase.

This review confirms that grey matter deficits are present in patients with first-episode psychosis (Hulshoff-Pol et al, 2001), whereas white matter changes have seldom been described (Sanfilipo et al, 2000; Hulshoff-Pol et al, 2004). Yet it is still not known whether changes in grey matter volume at first episode are associated with disease progression itself or with the many correlates of disease, including antipsychotic medication, alcoholism, drug misuse, malnutrition or even social deprivation. Both alcoholism (Joyce, 1996) and malnutrition (Swayze et al, 1996) are associated with acutely reversible changes in brain volume. Such volumetric changes are postulated to result from changes in brain water content, secondary to systemic hydration or serum protein content (Joyce, 1996; Swayze et al, 1996). Similar hydration mechanisms could be important in schizophrenia, since many patients suffer from malnutrition, dehydration and exposure (Shenton et al, 2001), so it is important to control for such environmental effects in studies.

It remains to be determined whether schizophrenia is a neurodegenerative process that begins at about the time of symptom onset and manifests as progressive volumetric loss thereafter, or whether it is better characterised as a neurodevelopmental process that results in abnormal brain volume beginning at an early age (Maynard et al, 2001).

TOP ABSTRACT INTRODUCTION METHOD RESULTS DISCUSSION ACKNOWLEDGMENTS REFERENCES

 
R.G.S. is supported by the National Alliance for Research on Schizophrenia and Depression as a Hofmann Trust Investigator. Our research was also supported by MH61603 (J.A.L.), the University of North Carolina at Chapel Hill Schizophrenia Research Center, the National Institute of Mental Health Silvio Conte Center for the Neuroscience of Mental Disorders (MH164065) and the Foundation of Hope.

TOP ABSTRACT INTRODUCTION METHOD RESULTS DISCUSSION ACKNOWLEDGMENTS REFERENCES

 

1. Antonova, E., Sharma, T., Morris, R., et al (2004) The relationship between brain structure and neurocognition in schizophrenia: a selective review. Schizophrenia Research, 70, 117 –145.[CrossRef][Medline]
2. Bachmann, S., Pantel, J., Flender, A., et al (2003) Corpus callosum in first-episode patients with schizophrenia – a magnetic resonance imaging study. Psychological Medicine, 33, 1019 –1027.[CrossRef][Medline]
3. Ballester, M. A. G., Zisserman, A. & Brady, M. (2000) Segmentation and measurement of brain structures in MRI including confidence bounds. Medical Image Analysis, 4, 189 –200.[CrossRef][Medline]
4. Barr, W. B., Ashtari, M., Bilder, R. M., et al (1997) Brain morphometric comparison of first-episode schizophrenia and temporal lobe epilepsy. British Journal of Psychiatry, 170, 515 –519.[Abstract/Free Full Text]
5. Bilder, R. M., Wu, H., Bogerts, B., et al (1994) Absence of regional hemispheric volume asymmetries in first-episode schizophrenia. American Journal of Psychiatry, 151, 1437 –1447.[Abstract/Free Full Text]
6. Bogerts, B., Ashtari, M., Degreef, G., et al (1990) Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia. Psychiatry Research, 35, 1 –13.[Medline]
7. Cahn, W., Hulshoff Pol, H. E., Bongers, M., et al (2002a) Brain morphology in antipsychotic-naïve schizophrenia: a study of multiple brain structures. British Journal of Psychiatry, 181 (suppl. 43), s66–s72.[CrossRef]
8. Cahn, W., Hulshoff Pol, H. E., Lems, E. B., et al (2002b) Brain volume changes in first-episode schizophrenia: a 1-year follow-up study. Archives of General Psychiatry, 59, 1002 –1010.[Abstract/Free Full Text]
9. Chakos, M. H., Lieberman, J. A., Bilder, R. M., et al (1994) Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. American Journal of Psychiatry, 151, 1430 –1436.[Abstract/Free Full Text]
10. Chua, S. E., Lam, I. W., Tai, K. S., et al (2003) Brain morphological abnormality in schizophrenia is independent of country of origin. Acta Psychiatrica Scandinavica, 108, 269 –275.[CrossRef][Medline]
11. Copolov, D., Velakoulis, D., McGorry, P., et al (2000) Neurobiological findings in early phase schizophrenia. Brain Research Reviews, 31, 157 –165.[CrossRef][Medline]
12. Corson, P. W., Nopoulos, P., Andreasen, N. C., et al (1999) Caudate size in first-episode neuroleptic-naive schizophrenic patients measured using an artificial neural network. Biological Psychiatry, 46, 712 –720.[CrossRef][Medline]
13. Crespo-Facorro, B., Kim, J., Andreasen, N. C., et al (2000) Insular cortex abnormalities in schizophrenia: a structural magnetic resonance imaging study of first-episode patients. Schizophrenia Research, 46, 35 –43.[CrossRef][Medline]
14. Davidson, L. L. & Heinrichs, R. W. (2003) Quantification of frontal and temporal lobe brain-imaging findings in schizophrenia: a meta-analysis. Neuroimaging, 122, 69 –87.[Medline]
15. Degreef, G., Ashtari, M., Wu, H. W., et al (1991) Follow-up MRI study in first episode schizophrenia. Schizophrenia Research, 5, 204 –206.[CrossRef][Medline]
16. Degreef, G., Ashtari, M., Bogerts, B., et al (1992) Volumes of ventricular system subdivisions measured from magnetic resonance images in first-episode schizophrenic patients. Archives of General Psychiatry, 49, 531 –537.[Abstract/Free Full Text]
17. DeLisi, L. E., Hoff, A. L., Schwartz, J. E., et al (1991) Brain morphology in first-episode schizophrenic-like psychotic patients: a quantitative magnetic resonance imaging study. Biological Psychiatry, 29, 159 –175.[Medline]
18. DeLisi, L. E., Stritzke, P., Riordan, H., et al (1992) The timing of brain morphological changes in schizophrenia and their relationship to clinical outcome. Biological Psychiatry, 31, 241 –254.[Medline]
19. DeLisi, L. E., Hoff, A. L., Neale, C., et al (1994) Asymmetries in the superior temporal lobe in male and female first-episode schizophrenic patients: measures of the planum temporale and superior temporal gyrus by MRI. Schizophrenia Research, 12, 19 –28.[CrossRef][Medline]
20. DeLisi, L. E., Tew, W., Xie, S., et al (1995) A prospective follow-up study of brain morphology and cognition in first-episode schizophrenic patients: preliminary findings. Biological Psychiatry, 38, 349 –360.[CrossRef][Medline]
21. DeLisi, L. E., Sakuma, M., Tew, W., et al (1997) Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Research, 74, 129 –140.[CrossRef][Medline]
22. DeLisi, L. E., Sakuma, M., Ge, S., et al (1998) Association of brain structural change with the heterogeneous course of schizophrenia from early childhood through five years subsequent to a first hospitalization. Psychiatry Research, 84, 75 –88.[Medline]
23. Ettinger, U., Chitnis, X. A., Kumari, V., et al (2001) Magnetic resonance imaging of the thalamus in first-episode psychosis. American Journal of Psychiatry, 158, 116 –118.[Abstract/Free Full Text]
24. Fannon, D., Tennakoon, L., O’Ceallaigh, S., et al (2000a) Third ventricle enlargement and developmental delay in first-episode psychosis: preliminary findings. British Journal of Psychiatry, 177, 354 –359.[Abstract/Free Full Text]
25. Fannon, D., Chitnis, X., Deku, V., et al (2000b) Features of structural brain abnormality detected in first-episode psychosis. American Journal of Psychiatry, 157, 1829 –1834.[Abstract/Free Full Text]
26. Giedd, J. N., Blumenthal, J., Jeffries, N. O., et al (1999) Brain development during childhood and adolescence: a longitudinal MRI study. Nature Neuroscience, 2, 861 –863.[CrossRef][Medline]
27. Gilbert, A. R., Rosenberg, D. R., Harenski, K., et al (2001) Thalamic volumes in patients with first-episode schizophrenia. American Journal of Psychiatry, 158, 618 –624.[Abstract/Free Full Text]
28. Gunduz, H., Wu, H., Ashtari, M., et al (2002) Basal ganglia volumes in first-episode schizophrenia and healthy comparison subjects. Biological Psychiatry, 51, 801 –808.[CrossRef][Medline]
29. Gur, R. E., Cowell, P., Turetsky, B. I., et al (1998) A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures. Archives of General Psychiatry, 55, 145 –152.[Abstract/Free Full Text]
30. Haller, J. W., Banerjee, A., Christensen, G. E., et al (1997) Three-dimensional hippocampal MR morphometry with high-dimensional transformation of a neuroanatomic atlas. Radiology, 202, 504 –510.[Abstract/Free Full Text]
31. Harrison, P. J. (1999) The neuropathology of schizophrenia: a critical review of the data and their interpretation. Brain, 122, 593 –624.[Abstract/Free Full Text]
32. Harrison, P. J., Freemantle, N. & Geddes, J. R. (2003) Meta-analysis of brain weight in schizophrenia. Schizophrenia Research, 64, 25 –34.[CrossRef][Medline]
33. Hirayasu, Y., Sheton, M. E., Salisbury, D. F., et al (1998) Lower left temporal lobe MRI volumes in patients with first-episode schizophrenia compared with psychotic patients with first-episode affective disorder and normal subjects. American Journal of Psychiatry, 155, 1384 –1391.[Abstract/Free Full Text]
34. Hirayasu, Y., Shenton, M. E., Salisbury, D. F., et al (1999) Subgenual cingulate cortex volume in first-episode psychosis. American Journal of Psychiatry, 156, 1091 –1093.[Abstract/Free Full Text]
35. Hirayasu, Y., Shenton, M. E., Salisbury, D. F., et al (2000a) Hippocampal and superior temporal gyrus volume in first-episode schizophrenia. Archives of General Psychiatry, 57, 618 –619.[Free Full Text]
36. Hirayasu, Y., McCarley, R. W., Salisbury, D. F., et al (2000b) Planum temporale and Heschl gyrus volume reduction in schizophrenia: a magnetic resonance imaging study of first-episode patients. Archives of General Psychiatry, 57, 692 –699.[Abstract/Free Full Text]
37. Hirayasu, Y., Tanaka, S., Shenton, M. E., et al (2001) Prefrontal gray matter volume reduction in first episode schizophrenia. Cerebral Cortex, 11, 374 –381.[Abstract/Free Full Text]
38. Ho, B. C., Andreasen, N. C., Nopoulos, P., et al (2003) Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. Archives of General Psychiatry, 60, 585 –594.[Abstract/Free Full Text]
39. Hoff, A. L., Neal, C., Kushner, M., et al (1994) Gender differences in corpus callosum size in first-episode schizophrenics. Biological Psychiatry, 35, 913 –919.[CrossRef][Medline]
40. Howard, M. A., Roberts, N., Garcia-Finana, M., et al (2003) Volume estimation of pre-frontal cortical subfields using MRI and stereology. Brain Research. Brain Research Protocols, 10, 125 –138.[CrossRef][Medline]
41. Hulshoff-Pol, H. E., Schnack, H. G., Mandl, R. C., et al (2001) Focal gray matter density changes in schizophrenia. Archives of General Psychiatry, 58, 1118 –1125.[Abstract/Free Full Text]
42. Hulshoff-Pol, H. E., Brans, R. G. H., van Haren, N. E. M., et al (2004) Gray and white matter volume abnormalities in monozygotic and same-gender dizygotic twins discordant for schizophrenia. Biological Psychiatry, 55, 126 –130.[CrossRef][Medline]
43. James, A. C., Crow, T. J., Renowden, S., et al (1999) Is the course of brain development in schizophrenia delayed? Evidence from onsets in adolescence. Schizophrenia Research, 40, 1 –10.[CrossRef][Medline]
44. Joyal, C. C., Laakso, M. P., Tiihonen, J., et al (2002) A volumetric MRI study of the entorhinal cortex in first episode neuroleptic-naive schizophrenia. Biological Psychiatry, 51, 1005 –1007.[CrossRef][Medline]
45. Joyal, C. C., Laakso, M. P., Tiihonen, J., et al (2003) The amygdala and schizophrenia: a volumetric magnetic resonance imaging study in first-episode, neurolepticnaive patients. Biological Psychiatry, 54, 1302 –1304.[CrossRef][Medline]
46. Joyce, E. M. (1996) Aetiology of alcoholic brain damage: alcoholic neurotoxicity or thiamine malnutrition? British Medical Bulletin, 50, 99 –114.
47. Kasai, K., Iwanami, A., Yamasue, H., et al (2002) Neuroanatomy and neurophysiology in schizophrenia. Neuroscience Research, 43, 93 –110.[CrossRef][Medline]
48. Kasai, K., Shenton, M. E., Salisbury, D. F., et al (2003a) Differences and similarities in insular and temporal pole MRI gray matter volume abnormalities in first-episode schizophrenia and affective psychosis. Archives of General Psychiatry, 60, 1069 –1077.[Abstract/Free Full Text]
49. Kasai, K., Shenton, M. E., Salisbury, D. F., et al (2003b) Progressive decrease of left Heschl gyrus and planum temporale gray matter volume in first-episode schizophrenia: a longitudinal magnetic resonance imaging study. Archives of General Psychiatry, 60, 766 –775.[Abstract/Free Full Text]
50. Kasai, K., Shenton, M. E., Salisbury, D. F., et al (2003c) Progressive decrease of left superior temporal gyrus graymatter volume in patients with first-episode schizophrenia. American Journal of Psychiatry, 160, 156 –164.[Abstract/Free Full Text]
51. Keshavan, M. S., Rosenberg, D., Sweeney, J. A., et al (1998a) Decreased caudate volume in neuroleptic-naive psychotic patients. American Journal of Psychiatry, 155, 774 –778.[Abstract/Free Full Text]
52. Keshavan, M. S., Rosenberg, D., Sweeney, J. A., et al (1998b) Superior temporal gyrus and the course of early schizophrenia: progressive, static, or reversible? Journal of Psychiatric Research, 32, 161 –167.[CrossRef][Medline]
53. Konick, L. C. & Friedman, L. (2001) Meta-analysis of thalamic size in schizophrenia. Biological Psychiatry, 49, 28 –38.[CrossRef][Medline]
54. Laakso, M. P., Tiihonen, J., Syvalahti, E., et al (2001) A morphometric MRI study of the hippocampus in first-episode, neuroleptic-naive schizophrenia. Schizophrenia Research, 50, 3 –7.[CrossRef][Medline]
55. Lang, D. J., Kopala, L. C., Vandorpe, R. A., et al (2001) An MRI study of basal ganglia volumes in first-episode schizophrenia patients treated with risperidone. American Journal of Psychiatry, 158, 625 –631.[Abstract/Free Full Text]
56. Lawrie, S. M., Whalley, H., Kestelman, J. M., et al (1999) Magnetic resonance imaging of brain in people at high risk of developing schizophrenia. Lancet, 353, 30 –33.[CrossRef][Medline]
57. Lee, C. U., Shenton, M. E., Salisbury, D. F., et al (2002) Fusiform gyrus volume reduction in first-episode schizophrenia: a magnetic resonance imaging study. Archives of General Psychiatry, 59, 775 –781.[Abstract/Free Full Text]
58. Lieberman, J. A., Alvir, J. M., Woerner, M., et al (1992) Prospective study of psychobiology in first-episode schizophrenia at Hillside Hospital. Schizophrenia Bulletin, 18, 351 –371.[Abstract/Free Full Text]
59. Lieberman, J., Chakos, M., Wu, H., et al (2001) Longitudinal study of brain morphology in first episode schizophrenia. Biological Psychiatry, 49, 487 –499.[CrossRef][Medline]
60. Lim, K. O., Tew, W., Kushner, M., et al (1996) Cortical gray matter volume deficit in patients with first-episode schizophrenia. American Journal of Psychiatry, 153, 1548 –1553.[Abstract/Free Full Text]
61. MacFall, J. R., Payne, M. E. & Krishnan, K. R. R. (2004) MR scanner geometry changes: phantom measurements compared to intracranial contents calculations. Proceedings of the International Society for Magnetic Resonance in Medicine, 11, 2182.
62. Matsumoto, H., Simmons, A., Williams, S., et al (2001a) Structural magnetic imaging of the hippocampus in early onset schizophrenia. Biological Psychiatry, 49, 824 –831.[CrossRef][Medline]
63. Matsumoto, H., Simmons, A., Williams, S., et al (2001b) Superior temporal gyrus abnormalities in early-onset schizophrenia: similarities and differences with adult-onset schizophrenia. American Journal of Psychiatry, 158, 1299 –1304.[Abstract/Free Full Text]
64. Maynard, T. M., Sikich, L., Lieberman, J. A., et al (2001) Neural development, cell–cell signaling, and the ‘two-hit’ hypothesis of schizophrenia. Schizophrenia Bulletin, 27, 457 –476.[Abstract/Free Full Text]
65. McCarley, R. W., Salisbury, D. F., Hirayasu, Y., et al (2002) Association between smaller left posterior superior temporal gyrus volume on magnetic resonance imaging and smaller left temporal P300 amplitude in first-episode schizophrenia. Archives of General Psychiatry, 59, 321 –331.[Abstract/Free Full Text]
66. Nelson, M. D., Saykin, A. J., Flashman, L. A., et al (1998) Hippocampal volume reduction in schizophrenia as assessed by MRI: a meta-analytic study. Archives of General Psychiatry, 55, 433 –440.[Abstract/Free Full Text]
67. Niemann, K., Hammers, A., Coenen, V. A., et al (2000) Evidence of a smaller left hippocampus and left temporal horn in both patients with first episode schizophrenia and normal control subjects. Psychiatry Research, 99, 93 –110.[Medline]
68. Nopoulos, P., Torres, I., Flaum, M., et al (1995) Brain morphology in first-episode schizophrenia. American Journal of Psychiatry, 152, 1721 –1723.[Abstract/Free Full Text]
69. Okubo, Y., Tomoyuki, S. & Oda, K. (2001) A review of MRI studies of progressive brain changes in schizophrenia. Journal of Medical and Dental Science, 48, 61 –67.
70. Pfefferbaum, A., Mathalon, D. H., Sullivan, E. V., et al (1994) A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood. Archives of Neurology, 51, 874 –887.[Abstract/Free Full Text]
71. Puri, B. K., Hutton, S. B., Saeed, N., et al (2001) A serial longitudinal quantitative MRI study of cerebral changes in first-episode schizophrenia using image segmentation and subvoxel registration. Psychiatry Research, 106, 141 –150.[Medline]
72. Razi, K., Greene, K. P., Sakuma, M., et al (1999) Reduction of the parahippocampal gyrus and the hippocampus in patients with chronic schizophrenia. British Journal of Psychiatry, 174, 512 –519.[Abstract/Free Full Text]
73. Salokangas, R. K. R., Cannon, T., Van Erp, T., et al (2002) Structural magnetic resonance imaging in patients with first-episode schizophrenia, psychotic and severe non-psychotic depression and healthy controls: results of the Schizophrenia and Affective Psychoses (SAP) project. British Journal of Psychiatry, 181 (suppl. 43), s58 –65.[CrossRef]
74. Sanfilipo, M., Lafargue, T., Rusinek, H., et al (2000) Volumetric measure of the frontal and temporal lobe regions in schizophrenia. Archives of General Psychiatry, 57, 471 –480.[Abstract/Free Full Text]
75. Shenton, M. E., Dickey, C. C., Frumin, M., et al (2001) A review of MRI findings in schizophrenia. Schizophrenia Research, 49, 1 –52.[Medline]
76. Siever, L. J. & Davis, K. L. (2004) The pathophysiology of schizophrenia disorders: perspectives from the spectrum. American Journal of Psychiatry, 161, 398 –413.[Abstract/Free Full Text]
77. Smith, G. N., Lang, D. J., Kopala, L. C., et al (2003) Developmental abnormalities of the hippocampus in first-episode schizophrenia. Biological Psychiatry, 53, 555 –561.[CrossRef][Medline]
78. Steen, R. G., Ogg, R., Reddick, W. E., et al (1997) Age-related changes in the pediatric brain: quantitative magnetic resonance imaging provides evidence of maturational changes during adolescence. American Journal of Neuroradiology, 18, 819 –828.[Abstract]
79. Suddath, R. L., Casanova, M. F., Goldberg, T. E., et al (1989) Temporal lobe pathology in schizophrenia: a quantitative magnetic resonance imaging study. American Journal of Psychiatry, 146, 464 –472.[Abstract/Free Full Text]
80. Sumich, A., Chitnis, X. A., Fannon, D. G., et al (2002) Temporal lobe abnormalities in first-episode psychosis. American Journal of Psychiatry, 159, 1232 –1235.[Abstract/Free Full Text]
81. Swayze, V. W., Anderson, A., Arndt, S., et al (1996) Reversibility of brain tissue loss in anorexia nervosa assessed with a computerized Talairach 3-D proportional grid. Psychological Medicine, 26, 381 –390.[Medline]
82. Szeszko, P. R., Bilder, R. M., Lenez, T., et al (1999) Investigation of frontal lobe subregions in first-episode schizophrenia. Psychiatry Research, 90, 1 –15.[Medline]
83. Szeszko, P. R., Gunning-Dixon, F., Ashtari, M., et al (2003a) Reversed cerebellar asymmetry in men with first-episode schizophrenia. Biological Psychiatry, 53, 450 –459.[CrossRef][Medline]
84. Szeszko, P. R., Goldberg, E., Gunduz-Bruce, H., et al (2003b) Smaller anterior hippocampal formation volume in antipsychotic-naive patients with first-episode schizophrenia. American Journal of Psychiatry, 160, 2190 –2197.[Abstract/Free Full Text]
85. Tofts, P. S., Barker, G. J., Filippi, M., et al (1997) An oblique cylinder contrast-adjusted (OCCA) phantom to measure the accuracy of MRI brain lesion volume estimation schemes in multiple sclerosis. Magnetic Resonance Imaging, 15, 183 –192.[CrossRef][Medline]
86. Torrey, E. F. (2002) Studies of individuals with schizophrenia never treated with antipsychotic medications: a review. Schizophrenia Research, 58, 101 –151.[CrossRef][Medline]
87. Uttal, W. (2001) The New Phrenology: The Limits of Localizing Cognitive Processes in the Brain.Cambridge, MA: MIT Press.
88. Velakoulis, D., Pantelis, C., McGorry, P. D., et al (1999) Hippocampal volume in first-episode psychoses and chronic schizophrenia: a high-resolution magnetic resonance imaging study. Archives of General Psychiatry, 56, 133 –141.[Abstract/Free Full Text]
89. Wang, D. & Doddrell, D. M. (2002) MR image-based measurement of rates of change in volumes of brain structures. Part 1: Method and validation. Magnetic Resonance Imaging, 20, 27 –40.[CrossRef][Medline]
90. Ward, K. E., Friedman, L., Wise, A., et al (1996) Metaanalysis of brain and cranial size in schizophrenia. Schizophrenia Research, 22, 197 –213.[CrossRef][Medline]
91. Whitworth, A. B., Honeder, M., Kremser, C., et al (1998) Hippocampal volume reduction in male schizophrenic patients. Schizophrenia Research, 31, 73 –81.[CrossRef][Medline]
92. Wood, S. J., Velakoulis, D., Smith, D. J., et al (2001) A longitudinal study of hippocampal volume in first episode psychosis and chronic schizophrenia. Schizophrenia Research, 52, 37 –46.[CrossRef][Medline]
93. Wright, I. C., Rabe-Hesketh, S., Woodruff, P. W. R., et al (2000) Meta-analysis of regional brain volumes in schizophrenia. American Journal of Psychiatry, 157, 16 –25.[Abstract/Free Full Text]
94. Zipursky, R. B., Lambe, E. K., Kapur, S., et al (1998a) Cerebral gray matter volume deficits in first episode psychosis. Archives of General Psychiatry, 55, 540 –546.[Abstract/Free Full Text]
95. Zipursky, R. B., Zhang-Wong, J., Lambe, E. K., et al (1998b) MRI correlates of treatment response in first episode psychosis. Schizophrenia Research, 30, 81 –90.[CrossRef][Medline]

Received for publication November 16, 2004. Revision received July 12, 2005. Accepted for publication August 18, 2005.

Related articles in BJP:

Highlights of this issue

KIMBERLIE DEAN
BJP 2006 188: 501-a21. [Full Text]  

This article has been cited by other articles:

				H. Jaaro-Peled, Y. Ayhan, M. V. Pletnikov, and A. Sawa Review of Pathological Hallmarks of Schizophrenia: Comparison of Genetic Models With Patients and Nongenetic Models Schizophr Bull, November 10, 2009; (2009) sbp133v1. [Abstract] [Full Text] [PDF]

				M. Leung, C. Cheung, K. Yu, B. Yip, P. Sham, Q. Li, S. Chua, and G. McAlonan Gray Matter in First-Episode Schizophrenia Before and After Antipsychotic Drug Treatment. Anatomical Likelihood Estimation Meta-analyses With Sample Size Weighting Schizophr Bull, September 16, 2009; (2009) sbp099v1. [Abstract] [Full Text] [PDF]

				R. C. K. Chan, X. Di, G. M. McAlonan, and Q.-y. Gong Brain Anatomical Abnormalities in High-Risk Individuals, First-Episode, and Chronic Schizophrenia: An Activation Likelihood Estimation Meta-analysis of Illness Progression Schizophr Bull, July 24, 2009; (2009) sbp073v1. [Abstract] [Full Text] [PDF]

				A. W. MacDonald and S. C. Schulz What We Know: Findings That Every Theory of Schizophrenia Should Explain Schizophr Bull, May 1, 2009; 35(3): 493 - 508. [Abstract] [Full Text] [PDF]

				L. Buchy, Y. Czechowska, C. Chochol, A. Malla, R. Joober, J. Pruessner, and M. Lepage Toward a Model of Cognitive Insight in First-Episode Psychosis: Verbal Memory and Hippocampal Structure Schizophr Bull, April 3, 2009; (2009) sbp015v1. [Abstract] [Full Text] [PDF]

				K. Sergerie, J. L. Armony, M. Menear, H. Sutton, and M. Lepage Influence of Emotional Expression on Memory Recognition Bias in Schizophrenia as Revealed by fMRI Schizophr Bull, January 27, 2009; (2009) sbn172v1. [Abstract] [Full Text] [PDF]

				S. Reig, C. Moreno, D. Moreno, M. Burdalo, J. Janssen, M. Parellada, A. Zabala, M. Desco, and C. Arango Progression of Brain Volume Changes in Adolescent-Onset Psychosis Schizophr Bull, January 1, 2009; 35(1): 233 - 243. [Abstract] [Full Text] [PDF]

				R. van Winkel, N. C. Stefanis, and I. Myin-Germeys Psychosocial Stress and Psychosis. A Review of the Neurobiological Mechanisms and the Evidence for Gene-Stress Interaction Schizophr Bull, November 1, 2008; 34(6): 1095 - 1105. [Abstract] [Full Text] [PDF]

				J. A. Lieberman, F. P. Bymaster, H. Y. Meltzer, A. Y. Deutch, G. E. Duncan, C. E. Marx, J. R. Aprille, D. S. Dwyer, X.-M. Li, S. P. Mahadik, et al. Antipsychotic Drugs: Comparison in Animal Models of Efficacy, Neurotransmitter Regulation, and Neuroprotection Pharmacol. Rev., September 1, 2008; 60(3): 358 - 403. [Abstract] [Full Text] [PDF]

				I. Ellison-Wright, D. C. Glahn, A. R. Laird, S. M. Thelen, and E. Bullmore The Anatomy of First-Episode and Chronic Schizophrenia: An Anatomical Likelihood Estimation Meta-Analysis Am J Psychiatry, August 1, 2008; 165(8): 1015 - 1023. [Abstract] [Full Text] [PDF]

				K. M. Prasad and M. S. Keshavan Structural Cerebral Variations as Useful Endophenotypes in Schizophrenia: Do They Help Construct "Extended Endophenotypes"? Schizophr Bull, July 1, 2008; 34(4): 774 - 790. [Abstract] [Full Text] [PDF]

				J. A. Lieberman, R. E. Drake, L. I. Sederer, A. Belger, R. Keefe, D. Perkins, and S. Stroup Science and Recovery in Schizophrenia Psychiatr Serv, May 1, 2008; 59(5): 487 - 496. [Abstract] [Full Text] [PDF]

				Bibliography Schizophrenia Focus, April 1, 2008; 6(2): 197 - 199. [Full Text] [PDF]

				S. J. Wood, C. Pantelis, D. Velakoulis, M. Yucel, A. Fornito, and P. D. McGorry Progressive Changes in the Development Toward Schizophrenia: Studies in Subjects at Increased Symptomatic Risk Schizophr Bull, March 1, 2008; 34(2): 322 - 329. [Abstract] [Full Text] [PDF]

				S. M. Lawrie, A. M. McIntosh, J. Hall, D. G.C. Owens, and E. C. Johnstone Brain Structure and Function Changes During the Development of Schizophrenia: The Evidence From Studies of Subjects at Increased Genetic Risk Schizophr Bull, March 1, 2008; 34(2): 330 - 340. [Abstract] [Full Text] [PDF]

				L. E. DeLisi The Concept of Progressive Brain Change in Schizophrenia: Implications for Understanding Schizophrenia Schizophr Bull, March 1, 2008; 34(2): 312 - 321. [Abstract] [Full Text] [PDF]

				S. Begre and T. Koenig Cerebral Disconnectivity: An Early Event in Schizophrenia Neuroscientist, February 1, 2008; 14(1): 19 - 45. [Abstract] [PDF]

				A. Konrad and G. Winterer Disturbed Structural Connectivity in Schizophrenia Primary Factor in Pathology or Epiphenomenon? Schizophr Bull, January 1, 2008; 34(1): 72 - 92. [Abstract] [Full Text] [PDF]

				J. A. Frazier, S. M. Hodge, J. L. Breeze, A. J. Giuliano, J. E. Terry, C. M. Moore, D. N. Kennedy, M. P. Lopez-Larson, V. S. Caviness, L. J. Seidman, et al. Diagnostic and Sex Effects on Limbic Volumes in Early-Onset Bipolar Disorder and Schizophrenia Schizophr Bull, January 1, 2008; 34(1): 37 - 46. [Abstract] [Full Text] [PDF]

				M. S. SCHAUFELBERGER, F. L.S. DURAN, J. M. LAPPIN, M. SCAZUFCA, E. AMARO Jr, C. C. LEITE, C. C. DE CASTRO, R. M. MURRAY, P. K. McGUIRE, P. R. MENEZES, et al. Grey matter abnormalities in Brazilians with first-episode psychosis The British Journal of Psychiatry, December 1, 2007; 191(51): s117 - s122. [Abstract] [Full Text] [PDF]

				J. THEBERGE, K. E. WILLIAMSON, N. AOYAMA, D. J. DROST, R. MANCHANDA, A. K. MALLA, S. NORTHCOTT, R. S. MENON, R. W. J. NEUFELD, N. RAJAKUMAR, et al. Longitudinal grey-matter and glutamatergic losses in first-episode schizophrenia The British Journal of Psychiatry, October 1, 2007; 191(4): 325 - 334. [Abstract] [Full Text] [PDF]

				J. L. Waddington Neuroimaging and other neurobiological indices in schizophrenia: relationship to measurement of functional outcome The British Journal of Psychiatry, August 1, 2007; 191(50): s52 - s57. [Abstract] [Full Text] [PDF]

				M. M Picchioni and R. M Murray Schizophrenia BMJ, July 14, 2007; 335(7610): 91 - 95. [Full Text] [PDF]

				R. G. Steen and R. M. Hamer Stressing About Posttraumatic Stress Disorder Pediatrics, July 1, 2007; 120(1): 232 - 234. [Full Text] [PDF]

				R.G. Steen, R.M. Hamer, and J.A. Lieberman Measuring Brain Volume by MR Imaging: Impact of Measurement Precision and Natural Variation on Sample Size Requirements AJNR Am. J. Neuroradiol., June 1, 2007; 28(6): 1119 - 1125. [Abstract] [Full Text] [PDF]

				A. Vita and L. de Peri Hippocampal and amygdala volume reductions in first-episode schizophrenia The British Journal of Psychiatry, March 1, 2007; 190(3): 271 - 271. [Full Text] [PDF]

This Article Abstract Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Related articles in BJP Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by STEEN, R. G. Articles by LIEBERMAN, J. A. Search for Related Content PubMed PubMed Citation Articles by STEEN, R. G. Articles by LIEBERMAN, J. A.